Enterome secures first tranche Series B
ENTEROME Bioscience has raised a first tranche of a Series B fundraising. The funding has been led by the company’s existing investors Seventure and Lundbeckfond Ventures. Omnes Capital also participated. Enterome is developing disease management solutions.
1 May 2014•4 mins read
